|
Larsucosterol Clinical Trials
1 actively recruiting trial across 1 location
No change since May 2026
Also known as: DUR928, DV928
Birmingham, Alabama1 trial
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
University of Alabama at Birmingham (UAB) Hospital
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.